SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-18-003249
Filing Date
2018-04-25
Accepted
2018-04-25 16:01:56
Documents
7
Period of Report
2018-06-12
Effectiveness Date
2018-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 925444
2 GRAPHIC def14ag001.jpg GRAPHIC 8959
3 GRAPHIC def14ag002.jpg GRAPHIC 6306
4 GRAPHIC def14ag003.gif GRAPHIC 106465
5 GRAPHIC def14ag004.gif GRAPHIC 56363
6 GRAPHIC def14ag005.gif GRAPHIC 75587
7 GRAPHIC def14ag006.gif GRAPHIC 83809
  Complete submission text file 0001558370-18-003249.txt   1391887
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38150 | Film No.: 18774338
SIC: 2834 Pharmaceutical Preparations